×
About 530,735 results

Benefits of Post-Op Penile Traction Therapy Hold Up Over Time
https://www.medpagetoday.com/urology/prostatecancer/95226

Oct 23rd, 2021 - SCOTTSDALE, Ariz. -- A penile traction therapy (PTT) device produced lasting improvements in men after prostatectomy, a researcher reported. The current data builds on an August 2021 study of 6-month data from 55 men (average age 58.6) who were randomly assigned to control (n=25) or treatment with PTT (n=30) after prostatectomy. The interventions began 1 month post-surgery, and those in the PTT...

Continuous-Release Anti-VEGF Device for AMD Wins FDA Approval
https://www.medpagetoday.com/ophthalmology/generalophthalmology/95225

Oct 23rd, 2021 - The FDA has approved a first-of-its kind continuous delivery system for anti-VEGF therapy for neovascular (wet) age-related macular degeneration (AMD). The Susvimo ocular implant continuously releases 100 mg/mL of ranibizumab directly to the retina over 6 months. Initial implantation and refill can be performed during an office visit with an ophthalmologist. In contrast, conventional intravitre...

Children With Cancer At Higher Risk for Severe Illness from COVID-19
https://www.onclive.com/view/children-with-cancer-at-higher-risk-for-severe-illness-from-covid-19

Oct 22nd, 2021 - Approximately 20% of pediatric patients with cancer infected with COVID-19 experienced severe illness, according to data published in The Lancet Oncology. Furthermore, deaths due to the infection were proportionally higher in this patient population compared with the general pediatric population, providing evidence that children with cancer are at higher risk of developing severe illness from C...

Dr. Yarchoan on Unique Characteristics of Fibrolamellar Carcinoma
https://www.onclive.com/view/dr-yarchoan-on-unique-characteristics-of-fibrolamellar-carcinoma

Oct 22nd, 2021 - Mark Yarchoan, MD, assistant professor of oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins Medicine, discusses unique characteristics of fibrolamellar carcinoma (FC). FC is a distinct type of liver cancer, Yarchoan says. Unlike hepatocellular carcinoma (HCC), which typically occurs in older patients who have underlying liver disease like cirrhosis, FC tends to occur in youn...

Dr. Burns on the Promise of Combination Regimens in EGFR Exon 20 Insertion+ and KRAS+ NSCLC
https://www.onclive.com/view/dr-burns-on-the-promise-of-combination-regimens-in-egfr-exon-20-insertion-and-kras-nsclc

Oct 22nd, 2021 - Timothy F. Burns, MD, PhD, medical oncologist, UPMC Hillman Cancer Center, associate professor of medicine, associate program director, Research, Hematology/Oncology Fellowship Program, University of Pittsburgh, discusses the promise of combination regimens for patients with EGFR exon 20 insertion– and KRAS G12C–mutated non–small cell lung cancer (NSCLC). Although the approvals of targeted...

Dr. Villaruz on Selecting Between Single-Agent and Combination Immunotherapy in NSCLC
https://www.onclive.com/view/dr-villaruz-on-selecting-between-single-agent-and-combination-immunotherapy-in-nsclc

Oct 22nd, 2021 - Liza C. Villaruz, MD, associate professor of medicine, medical oncologist, Division of Hematology/Oncology, UPMC Hillman Cancer Center, discusses selecting between single-agent and combination immunotherapy in non–small cell lung cancer (NSCLC). Several single-agent and combination immunotherapy regimens, such as nivolumab (Opdivo) plus ipilimumab (Yervoy), are approved for use in patients w...

How the pandemic prompted one clinic to embrace digital innovation
https://www.mdedge.com/dermatology/article/247790/business-medicine/how-pandemic-prompted-one-clinic-embrace-digital
Doug Brunk

Oct 22nd, 2021 - When the COVID-19 pandemic temporarily shuttered in-patient visits to a multispecialty practice in the San Francisco Bay Area in March of 2019, Olga Afanasiev, MD, PhD, and her colleagues saw an opportunity to create a new teledermatology workflow. Dr.

Exercise may help stall MS disability and progression
https://www.mdedge.com/neurology/article/247787/multiple-sclerosis/exercise-may-help-stall-ms-disability-and-progression
Jim Kling

Oct 22nd, 2021 - Though once regarded with suspicion, exercise as a therapy for multiple sclerosis (MS) has gained traction in recent years, and has the potential to counter the physical effects often seen among patients, as well as reduce risk of progression. Dr.

Walmart, Walgreens U.S. stores roll out Moderna, J&J COVID-19 booster shots
https://www.reuters.com/article/health-coronavirus-boosters/update-4-walmart-walgreens-u-s-stores-roll-out-moderna-jj-covid-19-booster-shots-idUSL4N2RI3BC

Oct 22nd, 2021 - (Reuters) -Walgreens Boots Alliance Inc and Walmart Inc said on Friday their U.S. pharmacies started administering COVID-19 booster shots from Moderna Inc and Johnson & Johnson, in addition to previously authorized Pfizer-BioNTech booster. The Centers for Disease Control and Prevention (CDC) on Thursday recommended J&J and Moderna’s booster shots and said Americans can choose a different shot f...

Study: Chronic GI Disorders Surfaced Months After COVID
https://www.medpagetoday.com/gastroenterology/irritablebowelsyndrome/95218

Oct 22nd, 2021 - Four in 10 COVID-19 patients from disadvantaged communities developed new post-COVID gastrointestinal disorders, including functional dyspepsia (FD) and irritable bowel syndrome (IBS), researchers found in a retrospective study. In a survey of 200 individuals, 39.5% developed de novo post-COVID gastrointestinal disorders, with 58 reporting FD-like complaints, two reporting IBS-like complaints, ...

HCA Healthcare's labor pains cast shadow on upbeat quarter
https://www.reuters.com/article/hca-healthcare-results/update-4-hca-healthcares-labor-pains-cast-shadow-on-upbeat-quarter-idUSL4N2RI2TL

Oct 22nd, 2021 - (Reuters) -HCA Healthcare Inc on Friday cautioned higher labor costs that tarnished strong third quarter profits could linger for longer as the hospital operator battles a staff crunch, sending the company’s shares down. A nationwide shortage of healthcare workers amid fatigue from a prolonged COVID-19 pandemic has forced hospitals to shell out more to hire and retain nurses and other staff ami...

Burnout a Risk Factor for Suicidal Thoughts in Nurses
https://www.medpagetoday.com/nursing/nursing/95217

Oct 22nd, 2021 - Nurses experiencing burnout were twice as likely to have thoughts of suicide, and those with symptoms of depression were 11 times as likely to experience suicidal thoughts, a survey study found. Among more than 7,000 nurses surveyed from November to December 2017, a total of 5.5% experienced suicidal ideation, which is higher than rates of suicidal thoughts in the general population (4.3%), rep...

How can doctors help kids recover from COVID-19 school disruptions?
https://www.mdedge.com/pediatrics/article/247777/mental-health/how-can-doctors-help-kids-recover-covid-19-school
Jake Remaly

Oct 22nd, 2021 - Physicians may be able to help students get back on track after the pandemic derailed normal schooling, a developmental and behavioral pediatrician suggests. The disruptions especially affected vulnerable students, such as those with disabilities and those affected by poverty.

A Wealth of Therapeutic Advances in Lung Cancer Stress a Need for Early NGS Testing
https://www.onclive.com/view/a-wealth-of-therapeutic-advances-in-lung-cancer-stress-a-need-for-early-ngs-testing

Oct 22nd, 2021 - The overwhelming number of options for the treatment of patients with lung cancer underscores the importance of broad molecular testing up front to ensure patients receive optimal care, said Stephen V. Liu, MD. Our strategies [for managing lung cancer] are becoming more sophisticated and precise, but the first step of broad next-generation sequencing [NGS] is really the key. NGS is essential t...

FDA Approves Companion Diagnostic for Adjuvant Atezolizumab in Stage II to IIIA NSCLC
https://www.onclive.com/view/fda-approves-companion-diagnostic-for-adjuvant-atezolizumab-in-stage-ii-to-iiia-nsclc

Oct 22nd, 2021 - The FDA has approved the VENTANA PD-L1 (SP263) assay to assist in identifying which adult patients with stage II to IIIA non–small cell lung cancer (NSCLC) whose tumors have PD-L1 expression on 1% or more of tumor cells are eligible to receive adjuvant atezolizumab (Tecentriq) following surgery and platinum-based chemotherapy.1 Adjuvant atezolizumab was approved for use in this indication on O...

Tissue Mapping Center for Cellular Senescence Launched at Yale Cancer Center to Study Human Lymphoid Organs
https://www.onclive.com/view/tissue-mapping-center-for-cellular-senescence-launched-at-yale-cancer-center-to-study-human-lymphoid-organs

Oct 22nd, 2021 - The National Institutes of Health (NIH) has awarded a grant to fund cellular senescence research in lymphoid organs at Yale Cancer Center. The five-year, $6.5 million grant will help generate multiscale molecular and cellular maps of cellular senescence in primary and secondary human lymphoid organs to improve our understanding of cellular senescence in development, aging, and disease, includin...

Factbox-Latest on the worldwide spread of the coronavirus
https://www.reuters.com/article/us-health-coronavirus-latest/factbox-latest-on-the-worldwide-spread-of-the-coronavirus-idUSKBN2HC0J2

Oct 22nd, 2021 - (Reuters) - Russia reported a fourth straight daily record of COVID-19 deaths with a week to go before the start of a workplace shutdown ordered by President Vladimir Putin, while Germany’s seven-day incidence rate rose sharply over the past week. * The UK Health Security Agency designated a Delta subvariant called AY.4.2 as a “Variant Under Investigation”, saying on Friday there was some evide...

CANADA STOCKS-TSX flat as weakness in tech, healthcare offset commodity-linked gains
https://www.reuters.com/article/canada-stocks/canada-stocks-tsx-flat-as-weakness-in-tech-healthcare-offset-commodity-linked-gains-idUSL4N2RI3BH

Oct 22nd, 2021 - (Updates prices, adds analyst comment) Oct 22 (Reuters) - Canada’s main stock index was little changed on Friday, as weakness in technology and healthcare stocks offset commodity-linked gains, however the benchmark index was on course for its third straight week of gains. At 9:42 a.m. ET (13:42 GMT), the Toronto Stock Exchange’s S&P/TSX composite index was down 5.76 points, or 0.03%, at 21,206....

Walgreens to administer Moderna, J&J COVID-19 booster shots at U.S. stores
https://www.reuters.com/article/health-coronavirus-boosters/walgreens-to-administer-moderna-jj-covid-19-booster-shots-at-u-s-stores-idUSL4N2RI3AO

Oct 22nd, 2021 - Oct 22 (Reuters) - Walgreens Boots Alliance Inc said on Friday customers can start receiving booster COVID-19 shots from Moderna Inc and Johnson & Johnson at its U.S. stores. The move comes after the Centers for Disease Control and Prevention (CDC) on Thursday recommended the additional doses and said Americans can choose a different shot from their original inoculation as a booster.

Many States Frown Upon Medicaid Coverage of Penile Implants for ED
https://www.medpagetoday.com/urology/erectiledysfunction/95204

Oct 22nd, 2021 - SCOTTSDALE, Ariz. -- At least 21 states still don't provide Medicaid coverage for penile implants in patients with erectile dysfunction (ED), a new study found. In contrast, 49 states cover male urethral slings, and 48 states cover insertion of artificial urinary sphincters for male incontinence, reported John Barnard, MD, of West Virginia University in Morgantown, who presented the findings at...